Catherine Eckford2025-02-06T11:40:31
The monoclonal antibody treatment is now approved in the US for both diabetic macular oedema and wet, or neovascular age-related macular degeneration.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-08-20T08:05:00Z
Sponsored by Sartorius
2026-06-29T06:00:00
Sponsored by Lubrizol Advanced Materials Europe BV
2026-03-27T15:37:00
Sponsored by IMA Pharma
2026-04-30T10:37:00
Sponsored by Shimadzu
2026-07-13T07:00:00
Sponsored by Thermo Fisher Scientific
2025-11-20T15:00:00
Sponsored by Rapid Micro Biosystems
2025-12-11T13:32:00
Sponsored by Hexagon
Site powered by Webvision Cloud